Systemic antibiotic prophylaxis does not affect infectious complications in pediatric burn injury: A meta-analysis
Authors:
Alexandra Csenkey aff001; Gergo Jozsa aff001; Noemi Gede aff003; Eszter Pakai aff001; Benedek Tinusz aff003; Zoltan Rumbus aff001; Anita Lukacs aff004; Zoltan Gyongyi aff005; Peter Hamar aff003; Robert Sepp aff006; Andrej A. Romanovsky aff007; Peter Hegyi aff003; Peter Vajda aff002; Andras Garami aff001
Authors place of work:
Department of Thermophysiology, Institute for Translational Medicine, Medical School, University of Pecs, Pecs, Hungary
aff001; Department of Paediatrics, Surgical Division, University of Pecs, Pecs, Hungary
aff002; Institute for Translational Medicine, Medical School, University of Pecs, Pecs, Hungary
aff003; Department of Public Health, Faculty of Medicine, University of Szeged, Szeged, Hungary
aff004; Department of Public Health Medicine, Medical School, University of Pecs, Pecs, Hungary
aff005; Second Department of Internal Medicine and Cardiology Centre, University Szeged, Szeged, Hungary
aff006; Thermoregulation and Systemic Inflammation Laboratory (FeverLab), Trauma Research, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States of America
aff007
Published in the journal:
PLoS ONE 14(9)
Category:
Research Article
doi:
https://doi.org/10.1371/journal.pone.0223063
Summary
In pediatric burns the use of systemic antibiotic prophylaxis is a standard procedure in some burn centers, though its beneficial effect on the infectious complications is debated. The present meta-analysis aimed at determining whether systemic antibiotic prophylaxis prevents infectious complications in pediatric patients with burn injuries. We searched the PubMed, EMBASE, and Cochrane Library databases from inception to August 2019. We included 6 studies, in which event rates of infectious complications were reported in children with burn injuries receiving or not receiving systemic antibiotic prophylaxis. We found that the overall odds ratio (OR) of developing an infection (including local and systemic) was not different between the groups (OR = 1.35; 95% CI, 0.44, 4.18). The chances for systemic infectious complications alone were also not different between antibiotic-treated and non-treated patients (OR = 0.74; 95% CI, 0.38, 1.45). Based on the age, affected total body surface area, and country income level, we did not find any subgroup that benefited from the prophylaxis. Our findings provide quantitative evidence for the inefficacy of systemic antibiotic prophylaxis in preventing infections in pediatric burns. To validate our conclusion, multinational, randomized trials in a diverse population of children with burn injuries are warranted.
Keywords:
Pediatrics – antibiotics – Database searching – Pediatric infections – Randomized controlled trials – Antibiotic prophylaxis – Burns
Introduction
Burn injuries in children constitute a major challenge for health care. The incidence and mortality rates of burns show a declining trend worldwide, mainly due to the decreased rates in highly developed countries [1], but several reports indicate an increasing incidence rate of burns in children in well-developed countries like Finland [2], the Netherlands [3], and the Czech Republic [4]. Children accounted for nearly 50% of the population with severe burn injuries in an analysis of studies from 22 European countries, which included data from more than 186,500 patients [5]. The majority of childhood burns occurred in children younger than 5 years of age [5]. In the US, burns were the third leading cause of unintentional injury and death for 1 to 9 year-old children in 2006 [6]. Of 1,559 injured children in low income countries in 2007, burns were also the third most frequent (13%) cause of injuries and had the highest (79%) admission rate among all types of unintentional injuries [7]. According to a recent global estimate, the overall child burn mortality is 2.5 per 100,000, and it is negatively correlated with the economic level of the country, being as high as 9.5 per 100,000 in low income countries such as Mongolia, Rwanda, and Togo [8]. The highest fire-related death rates occur in children younger than four years of age [6].
Burns can be caused by extreme heat (e.g., hot surfaces, fluids, and flame), chemicals, electricity, friction or radiation. Scald burns are the most frequent type of thermal injuries in children under the age of 5 years [5, 6], while between 5 and 16 years of age flame burns are most common [6]. The severity of the burn injury is influenced by several factors, including the nature and duration of the exposure, age and premorbid health and wealth conditions of the child, as well as regional and socioeconomic factors [6, 9]. Burns are classified based on the extent of the damage to the skin layers (depth of burns) and the size of affected skin area, assessed as percentage of total body surface area (TBSA) [10].
Infections, including wound, respiratory, and urinary tract infections, as well as those associated with sepsis, are among the most common complications of burns [11]. In pediatric patients, sepsis is a leading cause of mortality after burn injury, accounting for up to 54% of deaths [12, 13]. Burn wound infections and subsequently sepsis can occur in patients with partial-thickness or full-thickness burn injuries [11]; deeper burns present higher risk for infections [11, 14]. Despite these alarming data, there are no firm rules or guidelines for prophylactic, systemic antibiotic administration in pediatric patients with burn injury. It is recommended that systemic antibiotic administration should be reserved for cases with clear evidence of infection [10], but about 60% of the burn centers in the UK did not have a formal policy on the use of antibiotics, and there was no consensus on antibiotic prophylaxis, according to a study published in 1995 [15]. A more current survey revealed that standard operating procedures were implemented in less than half of UK burn units [16], and a recent study showed notable variations in guideline use for diagnosing and managing infections in pediatric burns [17]. Inappropriate use of antibiotics in burn injuries can increase the chance for complications [18] and result in antibiotic resistance [19], hence it can raise the cost of healthcare to both patients and the community [20]. The present meta-analysis of published clinical trials aims at determining whether systemic antibiotic prophylaxis improves the outcome of pediatric burn injuries. Similar analyses were performed in adult burn patients [21, 22] and helped to form guidelines [23].
Materials and methods
Search strategy
The meta-analysis was conducted as described in our recent studies [24, 25]. In brief, we followed the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols [26] (Table A in S1 File). The question of our analysis was formulated with the Participants, Intervention, Comparison, Outcome (PICO) model: in children with burn injury, we aimed to assess the effect of systemic antibiotic prophylaxis on infectious complications. This meta-analysis has been registered with PROSPERO International Prospective Register of Systematic Reviews (registration number: CRD42018102498).
We searched the PubMed, EMBASE, and Cochrane Library databases for relevant articles from inception to August 2019 with the following query: “(antibiotic* OR antimicrobial*) AND (prophylaxis OR prophylactic) AND (burn* OR scald OR flame) AND (pediatric* OR child*)”. Search results were filtered for human studies. The search was conducted separately by two authors (AC, GJ), who also assessed study eligibility and extracted data from the selected studies independently. Disagreements were resolved by consensus, if needed, with the help of a third party (AG). As a specific example for the search, in the EMBASE database, which identified the highest number of articles, the term “(antibiotic* OR antimicrobial*) AND (prophylaxis OR prophylactic) AND (burn* OR scald OR flame) AND (pediatric* OR child*)” was entered and retrieved 230 records, which decreased to 213 studies after the “humans” filter was selected.
Study selection and data extraction
After screening of the titles and abstracts of the publications identified with the literature search, the full texts of potentially eligible articles were obtained. We included studies which compared event rates of systemic and local complications of burns between children receiving and not receiving systemic antibiotic prophylaxis. Antibiotic prophylaxis was defined as systemic antibacterial drug administration to patients without confirmed infection and systemic inflammatory signs. Wound infection was considered as local complication, while systemic complications included sepsis and suspected toxic shock syndrome.
From the included studies, we extracted the country of origin, characteristics of the patient population (sample size, age, TBSA), and complication events in the different treatment groups (i.e., with or without systemic antibiotic prophylaxis) of children with burn injuries.
To evaluate the quality of the studies included in the meta-analysis, two independent reviewers (AC and BT) assessed the bias of a randomized controlled trial according to the Cochrane Risk of Bias Tool for Randomized Controlled studies [27] (Table B in S1 File), while the quality of other study types was assessed by using the Newcastle-Ottawa Scale [28] (Table C in S1 File).
Statistical analysis
The statistical analysis was performed according to the standard methods of meta-analysis. Patients were grouped as either treated with systemic antibiotic prophylaxis or not. Pooled odds ratio (OR) with 95% confidence intervals (CI) for infectious complications in pediatric patients with burn injuries were calculated for the dichotomous outcomes. In all forest plots, we applied the random-effect model with DerSimonian-Laird estimation. The OR was calculated by dividing the ratio of events to no events in the antibiotic-treated group with the same ratio in the group without systemic antibiotic prophylaxis. Statistical heterogeneity was determined by the I2 statistical test (P<0.1 indicating significant heterogeneity), while publication bias was assessed by the visual inspection of funnel plots (Figs A and B in S1 File), as described elsewhere [24, 25]. Heterogeneity in clinical outcomes was explored by creating different subgroups (age, income, TBSA, type of complication). Sensitivity analysis (i.e., iteratively removing one study from the analyses and recalculating OR to investigate the impact of each individual study on the summary estimate) showed no difference in the final pooled results. The analyses were performed using the Stata 11 SE software (StataCorp LLC, College Station, TX, USA).
Results
Study selection
Fig 1 presents the flow chart of the study selection. Until August 2019 the electronic literature search identified altogether 432 human studies from the PubMed, EMBASE, and Cochrane Library databases. After removing duplicates, 349 articles remained, which were screened on title and abstract for inclusion criteria. Full texts of 41 articles were reviewed and, in the end, 6 publications were found eligible for statistical analysis [18, 29–33], which included data from a total of 1,735 patients. The descriptive characteristics of these studies are shown in Table D in S1 File.
Effects of systemic antibiotic prophylaxis on local and systemic infectious complications in children with burn injuries
First, we analyzed whether systemic antibiotic prophylaxis has an effect on the OR for either local or systemic infectious complications. Studies which separately reported the event rates of local [18, 33] or systemic complications [18, 30, 31] were included in the forest plot (Fig 2). Prophylactic administration of systemic antibiotics did not cause a significant change in the odds for systemic infections (OR = 0.74; 95% CI, 0.38, 1.45). With regards to local complications, the use of antibiotics did not have a significant effect in either of the two included studies, however, their averaged result (OR = 0.99; 95% CI, 0.40, 2.47) should be taken with scrutiny due to the low number of studies in this subgroup. The odds of all infectious complications (i.e., both systemic and local) was also not significantly different between the antibiotic-treated and non-treated groups (OR = 0.82; 95% CI, 0.48, 1.40) (Fig 2).
Chance for infectious complications in different subgroups of pediatric burn patients treated or not treated with systemic antibiotic prophylaxis
Next, we divided the studies into different subgroups according to the known risk factors of the outcome of burns and data availability. Unlike in the first forest plot (Fig 2), where systemic and local complications were distinguished from each other, in the remaining part of our meta-analysis we considered all (i.e., both local and systemic) complications together as the outcome. Using the combined rate of complications allowed us to include two studies in the analysis, in which the separate event rates of local and systemic complications were not reported [29, 32]. Merging the rates of local and systemic complications looked rational, for we did not find a significant difference in the OR between systemic and local complications (Fig 2).
Based on the age range of the patient populations, the studies were assigned to either of two subgroups: limited to children only, viz., under 10 years of age [29, 30, 32], or also including adolescents up to the age of 16 years [18, 31, 33]. It should be mentioned that if the electronic search was expanded to children and adolescents, the number of eligible studies for quantitative analysis did not increase. Systemic antibiotic prophylaxis did not change the chance for complications in either of the age groups (Fig 3). The OR in the younger (children only) group was 1.75 (95% CI, 0.24, 13.09), while in the older group, which also included adolescents, it was 1.19 (95% CI, 0.44, 3.19). Antibiotic administration did not have any effect on the odds for infections when all 6 studies in the forest plot were combined (OR = 1.35, 95% CI, 0.44, 4.18) (Fig 3).
Based on the mean TBSA affected by the burns, the studies were divided into subgroups of less than 20% [18, 30, 31, 33] and more than 20% of injured TBSA [29, 32]. The reported values of TBSA are included in Table D in S1 File for each study. We did not find a significant effect of systemic antibiotic prophylaxis on the chance of infectious complications in the subgroup consisting of studies with less than 20% affected TBSA (OR = 0.84, 95% CI, 0.37, 1.91) (Fig 4). Though the OR was also not significant in the subgroup with more than 20% of injured TBSA, this group included only 2 studies, which is not sufficient for proper meta-analysis.
Regarding the economic status of the country of the studies, the studies were divided into high-income [30–33] and middle-income subgroups [18, 29] according to classification of the countries in the World Bank Data. Our analysis showed no significant effect of antibiotic prophylaxis on the chance for infections in either of the subgroups. The OR in the high-income subgroup was 1.35 (95% CI, 0.21, 8.77) (Fig 5). The use of antibiotics was also without an effect in either of 2 studies in middle-income countries (Fig 5), but caution is needed regarding their averaged OR due to the low number of studies in this subgroup.
Discussion
In the present study, we show that systemic antibiotic prophylaxis has no beneficial effects on the risk for infectious complications in pediatric burn injuries. By analyzing data of a total of 1,735 patients, we found that no patient subgroup (based on the age, injured TBSA or country income) benefited (in regards to odds for infectious complications) from receiving prophylactic antibiotic treatment, as compared to burn patients without antibiotic treatment.
Infectious complications are often feared as threats after burn injuries. Superficial burns (traditionally named as first-degree burn), which affect only the epidermis, usually do not require specialized medical care. On the contrary, in deeper burns, which penetrate into the dermis (i.e., partial-thickness, formerly second-degree) or damage the entire dermis and potentially even deeper tissues (i.e., full-thickness, formerly third- and higher-degree burns), the chance of infectious complications is proportionally increasing with the depth of the burn [11]. Deeper burns usually require complex conventional and surgical interventions [10, 34], among them partial-thickness burns are the most common type in children [9, 35, 36].
As part of the primary treatment of deeper burns, systemic antibiotic prophylaxis is occasionally initiated [15, 17], even though there is no clinical evidence for such indication of antimicrobial treatment. In fact, The International Society for Burn Injuries recommends to avoid prophylactic systemic antibiotics in acute burns [23], which guideline is based in part on meta-analyses of data obtained in adult burn patients [21, 22]. In pediatric burns, however, no meta-analysis has been performed, to the best of our knowledge, only a systematic review was published which lacked quantitative statistical analysis [37]. The present work aimed at filling this gap by conducting a meta-analysis of 6 articles [18, 29–33] identified based on an extensive literature search. We showed that systemic antibiotic prophylaxis did not decrease the chance for systemic and all infectious complications. As a matter of fact, when we included the rates of all infectious complications from all 6 eligible studies in our analysis, we found that the overall chance for developing an infection tended to be 35% higher in antibiotic-treated patients (n = 917) than in patients without antibiotic prophylaxis (n = 818), as indicated by the overall OR of 1.35 (95% CI, 0.44, 4.18) (Figs 3–5), although the difference did not reach the level of statistical significance. In accordance, a higher rate of infectious complications was reported in children with burn injuries who received antibiotic prophylaxis in two of the analyzed studies [18, 32]. It was thought to be due to the overgrowth of resistant microorganisms, thereby resulting in infections by opportunistic pathogens in the urinary tract, airways, and middle ear [18]. Antibiotic prophylaxis did not prevent wound infection or potential lethal consequences in the study in 80 pediatric patients with burn injuries conducted by Chahed et al. [29], which was, to our knowledge, the only randomized clinical trial designed to investigate the necessity of systemic antibiotic prophylaxis. Similarly, antibiotic prophylaxis was concluded to be unnecessary in two other studies [30, 33], whereas yet another suggested that prophylactic antibiotics may prevent toxic shock syndrome, based on data obtained from 50 pediatric patients with burn injuries [31]. It has to be noted, however, that in the latter study only 3 patients became septic in the entire study population: 2 (of 39) in the antibiotic-treated group and 1 (of 11) in the group without prophylaxis [31]. Due to the low numbers, these results should be interpreted with caution, as also noted by the authors.
The results of our meta-analysis regarding the lack of efficacy of prophylactic antibiotics on the overall infection rate in pediatric burns are in harmony with the conclusions drawn in the majority of previous human studies [18, 29, 30, 32, 33], a systematic review [37], and recent guidelines [23]. Moreover, by quantitative synthesis of the data reported in the identified articles, our results strengthen the body of evidence for the avoidance of systemic antibiotic prophylaxis in pediatric burns. However, pooling all reported data together and analyzing only the overall infection rate may mask a potentially beneficial effect of antibiotics in a specific subset of pediatric patients. Therefore, we also performed the meta-analysis in different subgroups, which were defined based on known risk factors reported in the identified studies. We found 3 parameters that were reported in sufficient details for subgroup analysis: age, affected TBSA, and country income. We assigned patients to subgroups based on these parameters. Remarkably, there was no statistical difference in the chance of infections between pediatric patients with and without systemic antibiotic prophylaxis in any of the three subgroups. These results suggest that systemic antibiotic prophylaxis should be avoided in pediatric burns independently of the age of pediatric patients, the injured TBSA, or the economic status of the country.
Certain limitations of our study must be also mentioned. Despite the extensive database search, only 6 studies could be included in the final analysis. This was sufficient for quantitative synthesis, but when we divided the studies into subgroups, in some cases only 2 studies per group remained. Although a review of the Cochrane Library revealed that numerous meta-analyses are conducted with two studies [38], firm conclusions should not be drawn from the meta-analysis of such small subgroups. All of the studies included in our meta-analysis were single-center studies, ranging from retrospective [18, 30, 33] to prospective [31, 32] to randomized clinical trials [29]. According to our quality assessment, only 3 studies were considered as good quality [18, 30, 32], while 2 studies as fair [31, 33], and 1 study as poor quality [29]. Based on visual inspection of the funnel plots (Figs A and B in S1 File), some asymmetry may be present, indicating the possible existence of publication bias, but statistical tests could not be performed, because for those at least 10 studies are required according to the Cochrane Handbook [39]. The depths of the burns in the patient populations were not reported in sufficient details to allow for subgroup analysis of the infectious outcome separately in partial- and full-thickness burns. Neither could we extract sufficient data about the latency from the time of the burn injury till initiation and the duration of the systemic antibiotic prophylaxis. Infectious comorbidities (or the lack of such) which had been already present in the children before they suffered burn injury could not be assessed from the studies. Finally, the antibiotics administered to the children varied among the studies. While penicillins were used most commonly for the prophylaxis [18, 29–31, 33], cephalosporins [18, 33] and macrolides [18, 30, 31] were also used in some cases, while, in one study [32], the antibiotic was not identified. All these factors could influence infectious outcomes (whether systemic or local) in pediatric patients with burn injuries, but, due to data unavailability, we could not account for these factors in the present meta-analysis. The mentioned statistical, methodological, and medical differences in study design can explain the considerably high between-study heterogeneity (indicated by an I2 of ~80%), as observed in our analysis (Figs 3–5). To account for the presence of heterogeneity, we used the random-effects model in all forest plots of our meta-analyses. We also performed leave-one-out sensitivity analysis to confirm that our findings were not driven by any single study. However, it is still possible that, despite all of our approaches to reduce methodological errors, the low number, different design and quality, and high heterogeneity of the analyzed studies may have negatively impacted our results.
In conclusion, the present study shows that systemic antibiotic prophylaxis as a routine has no benefits for the prevention of infectious complications in pediatric patients with burn injuries. Our meta-analysis of the data available in literature provides quantitative support to the position of avoiding routine use of the systemic antibiotic prophylaxis in pediatric burns. In addition to the quantitative synthesis of the available data, which to our knowledge, is the first in its field, we point out certain limitations in study design and data reporting, which, however, can also be addressed in the design of future clinical trials. Multinational, randomized controlled trials are warranted to validate our findings and prove unequivocally that routine systemic antibiotic prophylaxis is not indicated in pediatric patients with burn injuries.
Supporting information
Zdroje
1. Smolle C, Cambiaso-Daniel J, Forbes AA, Wurzer P, Hundeshagen G, Branski LK, et al. Recent trends in burn epidemiology worldwide: A systematic review. Burns. 2017;43(2):249–57. doi: 10.1016/j.burns.2016.08.013 27600982.
2. Laitakari E, Koljonen V, Rintala R, Pyorala S, Gissler M. Incidence and risk factors of burn injuries among infants, Finland 1990–2010. J Pediatr Surg. 2015;50(4):608–12. doi: 10.1016/j.jpedsurg.2014.05.034 25840072.
3. Vloemans AF, Dokter J, van Baar ME, Nijhuis I, Beerthuizen GI, Nieuwenhuis MK, et al. Epidemiology of children admitted to the Dutch burn centres. Changes in referral influence admittance rates in burn centres. Burns. 2011;37(7):1161–7. doi: 10.1016/j.burns.2011.05.001 21726947.
4. Celko AM, Grivna M, Danova J, Barss P. Severe childhood burns in the Czech Republic: risk factors and prevention. Bull World Health Organ. 2009;87(5):374–81. doi: 10.2471/BLT.08.059535 19551256.
5. Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care. 2010;14(5):R188. doi: 10.1186/cc9300 20958968.
6. Peck MD. Epidemiology of burns throughout the world. Part I: distribution and risk factors. Burns. 2011;37(7):1087–100. doi: 10.1016/j.burns.2011.06.005 21802856.
7. Hyder AA, Sugerman DE, Puvanachandra P, Razzak J, El-Sayed H, Isaza A, et al. Global childhood unintentional injury surveillance in four cities in developing countries: a pilot study. Bull World Health Organ. 2009;87(5):345–52. doi: 10.2471/BLT.08.055798 19551252.
8. Sengoelge M, El-Khatib Z, Laflamme L. The global burden of child burn injuries in light of country level economic development and income inequality. Prev Med Rep. 2017;6:115–20. doi: 10.1016/j.pmedr.2017.02.024 28316905.
9. Park JO, Shin SD, Kim J, Song KJ, Peck MD. Association between socioeconomic status and burn injury severity. Burns. 2009;35(4):482–90. doi: 10.1016/j.burns.2008.10.007 19216029.
10. Jamshidi R, Sato TT. Initial assessment and management of thermal burn injuries in children. Pediatr Rev. 2013;34(9):395–404. doi: 10.1542/pir.34-9-395 24000343.
11. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403–34. doi: 10.1128/CMR.19.2.403-434.2006 16614255.
12. Geyik MF, Aldemir M, Hosoglu S, Tacyildiz HI. Epidemiology of burn unit infections in children. Am J Infect Control. 2003;31(6):342–6. 14608300.
13. Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care. 2009;13(6):R183. doi: 10.1186/cc8170 19919684.
14. Rodgers GL, Mortensen J, Fisher MC, Lo A, Cresswell A, Long SS. Predictors of infectious complications after burn injuries in children. Pediatr Infect Dis J. 2000;19(10):990–5. doi: 10.1097/00006454-200010000-00010 11055602.
15. Papini RP, Wilson AP, Steer JA, McGrouther DA, Parkhouse N. Wound management in burn centres in the United Kingdom. Br J Surg. 1995;82(4):505–9. Epub 1995/04/01. doi: 10.1002/bjs.1800820423 7613896.
16. Lymperopoulos NS, Jeevan R, Godwin L, Wilkinson D, Shokrollahi K, James MI. The introduction of standard operating procedures to improve burn care in the United Kingdom. J Burn Care Res. 2015;36(5):565–73. Epub 2014/12/17. doi: 10.1097/BCR.0000000000000210 25501782.
17. Davies A, Spickett-Jones F, Brock P, Coy K, Young A. Variations in guideline use and practice relating to diagnosis and management of infection in paediatric burns services in England and Wales: A national survey. Burns. 2017;43(1):215–22. doi: 10.1016/j.burns.2016.07.032 27597639.
18. Ergun O, Celik A, Ergun G, Ozok G. Prophylactic antibiotic use in pediatric burn units. Eur J Pediatr Surg. 2004;14(6):422–6. doi: 10.1055/s-2004-821065 15630646.
19. Soleymanzadeh-Moghadam S, Azimi L, Amani L, Rastegar Lari A, Alinejad F, Rastegar Lari A. Analysis of antibiotic consumption in burn patients. GMS Hyg Infect Control. 2015;10:Doc09. Epub 2015/07/01. doi: 10.3205/dgkh000252 26124986.
20. Thorpe KE, Joski P, Johnston KJ. Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. Health Aff (Millwood). 2018;37(4):662–9. Epub 2018/03/22. doi: 10.1377/hlthaff.2017.1153 29561692.
21. Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ. 2010;340:c241. doi: 10.1136/bmj.c241 20156911.
22. Barajas-Nava LA, Lopez-Alcalde J, Roque i Figuls M, Sola I, Bonfill Cosp X. Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev. 2013;(6):CD008738. doi: 10.1002/14651858.CD008738.pub2 23740764.
23. Committee IPG, Steering S, Advisory S. ISBI Practice Guidelines for Burn Care. Burns. 2016;42(5):953–1021. doi: 10.1016/j.burns.2016.05.013 27542292.
24. Olah E, Poto L, Hegyi P, Szabo I, Hartmann P, Solymar M, et al. Therapeutic whole-body hypothermia reduces death in severe traumatic brain injury if the cooling index is sufficiently high: meta-analyses of the effect of single cooling parameters and their integrated measure. J Neurotrauma. 2018;35(20):2407–17. Epub 2018/04/24. doi: 10.1089/neu.2018.5649 29681213.
25. Rumbus Z, Matics R, Hegyi P, Zsiboras C, Szabo I, Illes A, et al. Fever is associated with reduced, hypothermia with increased mortality in septic patients: a meta-analysis of clinical trials. PLoS One. 2017;12(1):e0170152. doi: 10.1371/journal.pone.0170152 28081244.
26. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097 19621072.
27. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. Epub 2011/10/20. doi: 10.1136/bmj.d5928 22008217.
28. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000 [August, 2019]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
29. Chahed J, Ksia A, Selmi W, Hidouri S, Sahnoun L, Krichene I, et al. Burns injury in children: is antibiotic prophylaxis recommended? Afr J Paediatr Surg. 2014;11(4):323–5. doi: 10.4103/0189-6725.143141 25323182.
30. Mulgrew S, Khoo A, Cartwright R, Reynolds N. Morbidity in pediatric burns, toxic shock syndrome, and antibiotic prophylaxis: a retrospective comparative study. Ann Plast Surg. 2014;72(1):34–7. doi: 10.1097/SAP.0b013e31829be8be 24056250.
31. Rashid A, Brown AP, Khan K. On the use of prophylactic antibiotics in prevention of toxic shock syndrome. Burns. 2005;31(8):981–5. doi: 10.1016/j.burns.2005.06.017 16288963.
32. Rosanova MT, Stamboulian D, Lede R. Infections in burned children: epidemiological analysis and risk factors. Arch Argent Pediatr. 2013;111(4):303–8. doi: 10.1590/S0325-00752013000400008 23912287.
33. Sheridan RL, Weber JM, Pasternack MS, Tompkins RG. Antibiotic prophylaxis for group A streptococcal burn wound infection is not necessary. J Trauma. 2001;51(2):352–5. doi: 10.1097/00005373-200108000-00022 11493799.
34. Krishnamoorthy V, Ramaiah R, Bhananker SM. Pediatric burn injuries. Int J Crit Illn Inj Sci. 2012;2(3):128–34. doi: 10.4103/2229-5151.100889 23181206.
35. Natterer J, de Buys Roessingh A, Reinberg O, Hohlfeld J. Targeting burn prevention in the paediatric population: a prospective study of children's burns in the Lausanne area. Swiss Med Wkly. 2009;139(37–38):535–9. doi: smw-12605 19838870.
36. Rawlins JM, Khan AA, Shenton AF, Sharpe DT. Epidemiology and outcome analysis of 208 children with burns attending an emergency department. Pediatr Emerg Care. 2007;23(5):289–93. doi: 10.1097/01.pec.0000248698.42175.2b 17505269.
37. Lee F, Wong P, Hill F, Burgner D, Taylor R. Evidence behind the WHO guidelines: hospital care for children: what is the role of prophylactic antibiotics in the management of burns? J Trop Pediatr. 2009;55(2):73–7. doi: 10.1093/tropej/fmp017 19276147.
38. Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012;41(3):818–27. Epub 2012/03/31. doi: 10.1093/ije/dys041 22461129.
39. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 [August 2019]. Available from: www.handbook.cochrane.org.
Článek vyšel v časopise
PLOS One
2019 Číslo 9
- S diagnostikou Parkinsonovy nemoci může nově pomoci AI nástroj pro hodnocení mrkacího reflexu
- Proč při poslechu některé muziky prostě musíme tančit?
- Chůze do schodů pomáhá prodloužit život a vyhnout se srdečním chorobám
- „Jednohubky“ z klinického výzkumu – 2024/44
- Je libo čepici místo mozkového implantátu?
Nejčtenější v tomto čísle
- Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats
- CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
- Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
- Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania